IT7948691A0 - Composti della serie beta-lattamica procedimento per produrli e preparato farmaceutico che li comprende - Google Patents
Composti della serie beta-lattamica procedimento per produrli e preparato farmaceutico che li comprendeInfo
- Publication number
- IT7948691A0 IT7948691A0 IT7948691A IT4869179A IT7948691A0 IT 7948691 A0 IT7948691 A0 IT 7948691A0 IT 7948691 A IT7948691 A IT 7948691A IT 4869179 A IT4869179 A IT 4869179A IT 7948691 A0 IT7948691 A0 IT 7948691A0
- Authority
- IT
- Italy
- Prior art keywords
- beta
- compounds
- producing
- pharmaceutical preparation
- lactam series
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 150000003952 β-lactams Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Cephalosporin Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP53043624A JPS6034957B2 (ja) | 1978-04-12 | 1978-04-12 | ペニシラン酸誘導体 |
| JP53110464A JPS6037118B2 (ja) | 1978-09-07 | 1978-09-07 | ペニシラン酸誘導体 |
| JP53141785A JPS6037119B2 (ja) | 1978-11-16 | 1978-11-16 | ペニシラン酸誘導体 |
| JP53145638A JPS5951959B2 (ja) | 1978-11-24 | 1978-11-24 | ペニシラン酸誘導体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IT7948691A0 true IT7948691A0 (it) | 1979-04-10 |
| IT1162605B IT1162605B (it) | 1987-04-01 |
Family
ID=27461393
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT48691/79A IT1162605B (it) | 1978-04-12 | 1979-04-10 | Composti della serie beta-lattamica procedimento per produrli e preparato farmaceutico che li comprende |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4317820A (it) |
| AR (2) | AR227005A1 (it) |
| AT (1) | AT368159B (it) |
| AU (1) | AU524795B2 (it) |
| CA (1) | CA1133469A (it) |
| CH (1) | CH642081A5 (it) |
| DE (1) | DE2914218C2 (it) |
| DK (1) | DK149479A (it) |
| ES (2) | ES480281A1 (it) |
| FI (1) | FI70219C (it) |
| FR (1) | FR2422666A1 (it) |
| IT (1) | IT1162605B (it) |
| MX (1) | MX5704E (it) |
| NL (1) | NL180589C (it) |
| NO (2) | NO791223L (it) |
| PT (1) | PT69473A (it) |
| SE (1) | SE7903297L (it) |
| SU (1) | SU1151212A3 (it) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5792774A (en) * | 1996-02-21 | 1998-08-11 | Chiroscience Limited | Quinolones and their therapeutic use |
| US6525049B2 (en) | 2000-07-05 | 2003-02-25 | Pharmacia & Upjohn Company | Pyrroloquinolones as antiviral agents |
| PL1954697T3 (pl) * | 2005-10-21 | 2010-07-30 | Glaxo Group Ltd | Peri skondensowane tricykliczne związki użyteczne jako środki przeciwbakteryjne |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL175419C (nl) * | 1971-10-23 | 1984-11-01 | Bayer Ag | Werkwijze ter bereiding of vervaardiging van antibiotisch werkzame farmaceutische preparaten, alsmede werkwijze ter bereiding van antibiotisch werkzame alfa-gesubstitueerde 6-(alfa-(3-acylureido)acetylamino) penicillanzuurderivaten. |
| US3780034A (en) * | 1971-11-29 | 1973-12-18 | Merck & Co Inc | Process for preparing substituted cephalosporins |
| US3778432A (en) * | 1971-12-13 | 1973-12-11 | Merck & Co Inc | Isocyanates and carbamates of penicillins and 3-cephem-4-carboxylic acids |
| BE793524A (fr) | 1971-12-30 | 1973-06-29 | Riker Laboratories Inc | Acides benzoquinolizine-carboxyliques et leurs derives |
| US3954731A (en) * | 1972-07-03 | 1976-05-04 | Eli Lilly And Company | Process for preparing 6-alkoxypenicillanic and 7-alkoxycephalosporin acids |
| US3917609A (en) | 1973-06-27 | 1975-11-04 | Minnesota Mining & Mfg | Pyrroloquinoline carboxylic acids and derivatives |
| US4062842A (en) * | 1973-09-06 | 1977-12-13 | E. R. Squibb & Sons, Inc. | Method for preparing 7-substituted cephalosporins and 6-substituted penicillins by replacement of sulfur-containing groups |
| DE2559932C2 (de) | 1974-05-09 | 1983-04-21 | Toyama Chemical Co. Ltd., Tokyo | Cephalosporine, Verfahren zur Herstellung derselben und Mittel mit einem Gehalt derselben |
| US3962214A (en) * | 1974-07-11 | 1976-06-08 | Eli Lilly And Company | Process for preparing amino substituted β-lactam antibiotics |
-
1979
- 1979-04-09 DE DE2914218A patent/DE2914218C2/de not_active Expired
- 1979-04-10 IT IT48691/79A patent/IT1162605B/it active
- 1979-04-10 DK DK149479A patent/DK149479A/da not_active Application Discontinuation
- 1979-04-10 US US06/028,770 patent/US4317820A/en not_active Expired - Lifetime
- 1979-04-10 NO NO79791223A patent/NO791223L/no unknown
- 1979-04-11 AU AU46038/79A patent/AU524795B2/en not_active Ceased
- 1979-04-11 AR AR276166A patent/AR227005A1/es active
- 1979-04-11 SU SU792753360A patent/SU1151212A3/ru active
- 1979-04-11 ES ES480281A patent/ES480281A1/es not_active Expired
- 1979-04-11 CH CH343479A patent/CH642081A5/de not_active IP Right Cessation
- 1979-04-11 AT AT0269079A patent/AT368159B/de not_active IP Right Cessation
- 1979-04-11 PT PT69473A patent/PT69473A/pt unknown
- 1979-04-11 FI FI791190A patent/FI70219C/fi not_active IP Right Cessation
- 1979-04-11 MX MX797868U patent/MX5704E/es unknown
- 1979-04-11 CA CA325,375A patent/CA1133469A/en not_active Expired
- 1979-04-12 FR FR7909337A patent/FR2422666A1/fr active Granted
- 1979-04-12 NL NLAANVRAGE7902906,A patent/NL180589C/xx not_active IP Right Cessation
- 1979-04-12 SE SE7903297A patent/SE7903297L/xx unknown
-
1980
- 1980-01-30 ES ES488833A patent/ES488833A0/es active Granted
-
1981
- 1981-03-11 AR AR284582A patent/AR226883A1/es active
-
1984
- 1984-02-20 NO NO84840617A patent/NO840617L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO791223L (no) | 1979-10-15 |
| CA1133469A (en) | 1982-10-12 |
| FI70219C (fi) | 1986-09-15 |
| AR227005A1 (es) | 1982-09-15 |
| DE2914218A1 (de) | 1979-10-25 |
| ES8200339A1 (es) | 1981-11-16 |
| ATA269079A (de) | 1982-01-15 |
| IT1162605B (it) | 1987-04-01 |
| ES480281A1 (es) | 1980-08-16 |
| FI70219B (fi) | 1986-02-28 |
| SU1151212A3 (ru) | 1985-04-15 |
| PT69473A (en) | 1979-05-01 |
| NO840617L (no) | 1979-10-15 |
| ES488833A0 (es) | 1981-11-16 |
| NL7902906A (nl) | 1979-10-16 |
| NL180589B (nl) | 1986-10-16 |
| AU524795B2 (en) | 1982-10-07 |
| US4317820A (en) | 1982-03-02 |
| NL180589C (nl) | 1987-03-16 |
| SE7903297L (sv) | 1979-12-21 |
| FI791190A (fi) | 1979-10-13 |
| DK149479A (da) | 1979-10-13 |
| FR2422666A1 (fr) | 1979-11-09 |
| AU4603879A (en) | 1979-10-18 |
| MX5704E (es) | 1983-12-16 |
| AT368159B (de) | 1982-09-27 |
| DE2914218C2 (de) | 1985-10-24 |
| FR2422666B1 (it) | 1983-02-04 |
| AR226883A1 (es) | 1982-08-31 |
| CH642081A5 (de) | 1984-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO171556C (no) | Fremgangsmaate for fremstilling av azitromycin dihydrat | |
| SE7808356L (sv) | Forfarande for framstellning av liposomer | |
| IT1133075B (it) | Procedimento per la preparazione della monacolina k | |
| NO149913C (no) | Fremgangsmaate for fremstilling av lokalanestetisk virksomme kombinasjonspreparater | |
| NO148280C (no) | Fremgangsmaate for fremstilling av tetracyklinpreparater | |
| NO831861L (no) | Fremgangsmaate til fremstilling av en serie enkeltkrystallgjenstander | |
| NO834197L (no) | Fremgangsmaate for fremstilling av et sprengstoff | |
| NO771578L (no) | Fremgangsmaate for fremstilling av di-n-propyleddiksyre | |
| PT67676A (en) | Process for the preparation of bases for external use medicines and medicines obtained from such bases | |
| NO832022L (no) | Fremgangsmaate til fremstilling av amidiner | |
| NO844243L (no) | Fremgangsmaate for fremstilling av terapeutisk virksomme forbindelser | |
| IT7948690A0 (it) | Composti piperazinil-benzoeteroci clici procedimento per produrli e preparato farmaceutico che li con tiene | |
| NO830238L (no) | Fremgangsmaate for fremstilling av farmakologisk aktive urinstoffer og tiourinstoffer | |
| IT1105091B (it) | Composit eterociclici della serie dell'indolo con impiego farmaceutico e procedimento per la loro produzione | |
| NO834729L (no) | Fremgangsmaate for fremstilling av farmakologisk aktive tio-cefalosporiner | |
| NO831775L (no) | Fremgangsmaate for fremstilling av fermentert myse | |
| NO172547C (no) | Fremgangsmaate til fremstilling av nalfa-acetyl-eglin b og -c | |
| NO833527L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklobutylderivater | |
| IT7948691A0 (it) | Composti della serie beta-lattamica procedimento per produrli e preparato farmaceutico che li comprende | |
| NO813263L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater | |
| IT1070223B (it) | Composizione di fosforo luminescente e procedimento per la sua preparazione | |
| NO780743L (no) | Fremgangsmaate for fremstilling av farmakologisk aktive benzylpyrimidiner | |
| DK413279A (da) | Fremgangsmaade til fremstilling af natriumamoxicillin og injicerbare natriumamoxicillin-dosispraeparater og herved vundne praeparater | |
| NO834437L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive spiro-3-hetero-azolon-derivater | |
| NO803115L (no) | Fremgangsmaate for fremstilling av stivelselim |